by Heather Callaghan; Natural Blaze
Huge announcement—remarkable!
"According to researchers, the rebirth of human organs has now moved out of laboratory settings and into real-world medical practice."
Lately, scientific inquiry appears to be drifting away from embryonic stem cell applications. The reasons span ethical disputes, steep costs, technical hurdles, and unpredictable outcomes. Fortunately, our bodies already harbor regenerative stem cells capable of mending tissue wherever damage occurs.
These cells sidestep many of the pitfalls associated with alternative cellular treatments or organ transplantation. Stem cell-based medicine ranks among today's most striking medical advances—one that scientists themselves hesitate to label outright for fear of sounding too miraculous.
Throughout most of human history, pulmonary disease carried a near-certain fatal verdict. In a stunning turn of events, one individual is now breathing through newly rebuilt lungs, given a fresh start at living, all thanks to regenerative cellular therapy.
According to China Daily:
Earlier laboratory work involving mice suffering from lung fibrosis demonstrated that the condition could be reversed, with the animals and their respiratory organs reaching a notably healthy state within three weeks. At present, transplanted stem cells cannot mend every form of tissue damage, nor do they suit all categories of pulmonary illness. Still, the investigators maintain that measurable progress remains unmistakable.
Zuo noted that upwards of eighty individuals have taken part in clinical trials beginning in April 2016, with every participant showing gains in metrics including lung capacity and walking distance, GNN reports.
Dai Xiaotian, the physician heading the clinical investigations, indicated that additional participants will be enrolled this year and monitored over extended periods. The team also intends to apply the therapy to individuals suffering from kidney and uterine conditions.
For now, donor organs remain an undeniable lifeline. Yet the scarcity of available organs has fueled shadowy black-market operations and troubling practices within Western healthcare alike. On top of that, recipients face significant odds of organ rejection and a lifelong dependency on immunosuppressive medications.
This single accomplishment has ignited fresh optimism for a tomorrow where healing originates from within the patient rather than from external donors. Although the treatment remains in its early stages, such an approach to medicine would have seemed pure fantasy in earlier eras.
Watch Mel Gibson recount how his father, Hutton, nearly perished at age 92 before turning to stem cell therapy as a final option. (The physician who treated him authored the volume Stem Cell Therapy: A Rising Tide: How Stem Cells Are Disrupting Medicine and Transforming Lives.) Hutton Gibson is on track to celebrate his hundredth birthday this summer!
Heather Callaghan works as an independent researcher, author, public speaker, and advocate for food freedom. She serves as Editor and co-founder of NaturalBlaze and holds certification as a Self-Referencing IITM Practitioner.
